Additionally, the protective effects of the Nrf2-ARE signaling pathway have been demonstrated in models of NTG-induced migraines [56,130], suggesting that this pathway could serve as an effective therapeutic target for migraine patients. Here, NFE2L2 is linked to migraine disorder.